Classically, the basal ganglia have been considered to have a role in producing habitual
and goal-directed behaviours. In this article, we review recent evidence that expands this …

Deep brain stimulation (DBS) of 3 different targets is the most important therapeutic
innovation of the past 30 years for patients with fluctuating Parkinson's disease (PD) …

Background Although the short-term benefits of bilateral stimulation of the subthalamic
nucleus in patients with advanced Parkinson's disease have been well documented, the …

Deep brain stimulation (DBS) is an established procedure for the symptomatic treatment of
Parkinson's disease. Several deep brain nuclei have been stimulated, producing a wide …

Deep brain stimulation (DBS) has provided remarkable benefits for people with a variety of
neurologic conditions. Stimulation of the ventral intermediate nucleus of the thalamus can …

Insight into the organization of the basal ganglia in the normal, parkinsonian and l-dopa-
induced dyskinesia states is critical for the development of newer and more effective …

Deep-brain stimulation (DBS) of the subthalamic nucleus (STN) is an established treatment
for motor complications in Parkinson's disease. 20 years of experience with this procedure …

Background: The main advantage of deep brain stimulation (DBS) in the treatment of PD is
that the electrical settings can be adjusted to optimize benefits and minimize adverse effects …

Deep brain stimulation (DBS) of the subthalamic nucleus (STN) or the internal segment of
the globus pallidus (GPi) has recently been recognized as an important form of intervention …

Recent studies suggest that beta (15–30 Hz) oscillatory activity in the subthalamic nucleus
(STN) is dramatically increased in Parkinson's disease (PD) and may interfere with …